D Vanderghinste, M Van Eeckhoudt, C Terwinghe, L Mortelmans, G M Bormans, A M Verbruggen, H P Vanbilloen
文献索引:J. Pharm. Biomed. Anal. 32(4-5) , 679-85, (2003)
全文:HTML全文
99mTc-exametazime (99mTc-d,l-HMPAO, 99mTc-d,l-hexamethylpropyleneamine oxime) is a neutral rather unstable complex of short-lived 99mTc (t(1/2)=6 h) with the d,l-isomer (mixture of D,D- and L,L-isomers) of a bis-amine bis-oxime tetraligand. It is widely used for measurement of regional cerebral perfusion in nuclear medicine. The meso-isomer (D,L-form) should not be present in a preparation as it is not retained in brain and thus does not provide clinically useful information. Meso-HMPAO is removed from the ligand during the synthesis procedure by repeated recrystallization, but can still be present as impurity in d,l-isomer. Due to the lack of a suitable chromatographic method for analysis of the isomeric purity of 99mTc-exametazime preparations, United States Pharmacopoeia 25 (USP 25) prescribes a biological test in rats for quality control purpose. In this study, we developed a suitable high-performance liquid chromatography (HPLC) method which allows to demonstrate the relative amounts of d,l- and meso-isomer in 99mTc-exametazime and so obviates the need for a biodistribution test in animals as part of the quality control. Due to the low concentrations in which 99mTc-d,l-HMPAO is obtained (typically 2-6 ng/ml), confirmation of the identity of 99mTc-d,l-HMPAO in the monograph of the European Pharmacopoeia is now performed only indirectly by TLC and assessment of its retention time on RP-HPLC. To investigate the potential of radio-LC-MS for assessment of the identity of 99mTc-exametazime, 99mTc-d,l-HMPAO and 99mTc-meso-HMPAO prepared using a Tc-rich eluate were analyzed using a radio-LC-MS system equipped with a time-of-flight mass spectrometer with electrospray ionization. The main peak in the radiometric channel coincided with the molecular ion mass of 99mTc-d,l-HMPAO in the mass spectrometer channel and the measured accurate mass differed only by 0.26 ppm from the theoretical mass. The identity of 99mTc-meso-HMPAO was also confirmed. Thus, radio-LC-MS allowed to obtain strong evidence for the structure of 99mTc-d,l-HMPAO and 99mTc-meso-HMPAO at nanomolar concentration. It is concluded that radio-LC-MS can become a sensitive aid in quality control of "no carrier added" radiopharmaceutical preparations.
结构式 | 名称/CAS号 | 分子式 | 全部文献 |
---|---|---|---|
![]() |
依沙美肟
CAS:105613-48-7 |
C13H28N4O2 |
Nicotinic alpha4beta2 receptor binding in dementia with Lewy...
2008-04-15 [Neuroimage 40(3) , 1056-63, (2008)] |
Leukocyte SPECT/CT for detecting infection of left-ventricul...
2010-07-01 [J. Nucl. Med. 51(7) , 1044-8, (2010)] |
Chiral ligand-exchange chromatography for diastereo-enantio ...
2003-08-21 [J. Pharm. Biomed. Anal. 32(6) , 1159-66, (2003)] |
Consensus development for producing diagnostic procedure gui...
1994-12-01 [J. Nucl. Med. 35(12) , 2003-10, (1994)] |
Multivariate spatial covariance analysis of 99mTc-exametazim...
2013-04-01 [J. Cereb. Blood Flow Metab. 33(4) , 612-8, (2013)] |
首页 |
期刊大全 |
MSDS查询 |
化工产品分类 |
生物活性化合物 |
关于我们 |
免责声明:知识产权问题请联系 service1@chemsrc.com
Copyright © 2024 ChemSrc All Rights Reserved